The David Rubenstein Show cover image

The David Rubenstein Show

Vas Narasimhan

Mar 7, 2024
Novartis CEO Vas Narasimhan discusses transforming the company into an innovative medicines giant. Topics include pharmaceutical innovations, AI in drug research, sustainability efforts, diversity & inclusion, and essential skills for CEOs. Insights on career growth in the pharmaceutical industry and market investment opportunities.
23:48

Episode guests

Podcast summary created with Snipd AI

Quick takeaways

  • Constant innovation is crucial in the pharmaceutical industry due to patent expiration and the need to develop new medications.
  • Novartis is focused on advancing RNA therapeutics, cell therapy, and radioligand therapy to revolutionize healthcare treatments.

Deep dives

Key Products at Novartis

Novartis produces several major drugs like Entrusto for heart failure, Cosentix for immunology indications, and Kiskali for breast cancer, among others. These medicines contribute to over 15 products with sales exceeding a billion dollars, showcasing Novartis' extensive pharmaceutical portfolio.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode